5‐HT2C receptor agonists attenuate pain‐related behaviour in a rat model of trigeminal neuropathic pain
Authors:
- Kunihiro NakaiKNKunihiro Nakai
- Aya NakaeANAya Nakae
- Sosuke ObaSOSosuke Oba
- Takashi MashimoTMTakashi Mashimo
- Koichi UedaKUKoichi Ueda
- 1 November 2010
- journal article
- Published by Wiley in European journal of pain
- Vol. 14 (10) , 999-1006
Abstract
Peripheral branches of the trigeminal nerve may be damaged during maxillofacial injury or surgical procedures and trigeminal trauma may induce severe pain that is very challenging to treat. Chronic constriction injury to the infraorbital nerve (ION‐CCI) by loose ligatures has proven a useful model for some types of trigeminal neuropathic pain disorder. Using ION‐CCI rats, we examined the antiallodynic effects of intrathecally administered agents which are selective for 5‐HT2C receptors. Allodynia was evaluated by applying von Frey filaments to skin innervated by the injured ION. Dose‐dependent antiallodynic effects followed administration of three 5‐HT2C receptor agonists, 6‐chloro‐2‐(1‐piperazinyl)‐pyrazine (MK212: 10, 30, and 100 μg); (S)‐2‐(chloro‐5‐fluoro‐indol‐l‐yl)‐1‐methyamine fumarate (RO 60‐0175: 10, 30, and 100 μg); (AaR)‐8,9‐dichloro‐2,3,4,4a‐tetrahydro‐1H‐pyrazino[1,2‐a]quinoxalin‐5(6H)‐one (WAY‐161503: 10, 30, and 100 μg). ED50 values for antiallodynic effects of MK212, RO 60‐0175, and WAY‐161503 were 39.62, 46.67, and 51.22 μg, respectively. Intrathecal administration of the 5‐HT2C receptor antagonist, 8‐[5‐2,4‐dimethoxy‐5‐(4‐trifluoromethylphenylsulphonamido)phenyl‐5‐oxopentyl]‐1,3,8‐triazaspiro[4,5]decane‐2,4‐dione (RS‐102221: 30 μg) did not alter the mechanical threshold. Intrathecal pretreatment with RS‐102221 (10 and 30 μg) reduced the antiallodynic effects of the highest dose of 5‐HT2C agonists. These results indicated that, in this rat model, the 5‐HT2C receptor plays a role in spinal inhibition of trigeminal neuropathic pain.Keywords
This publication has 71 references indexed in Scilit:
- Further pharmacological characterization of 5‐HT2Creceptor agonist‐induced inhibition of 5‐HT neuronal activity in the dorsal raphe nucleusin vivoBritish Journal of Pharmacology, 2009
- Serotonin2C receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbensNeuropharmacology, 2009
- Selective activation of 5-HT2C receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: A combined in vivo electrophysiological and neurochemical studyNeuroscience, 2007
- In vivo evidence that 5‐HT2C receptors inhibit 5‐HT neuronal activity via a GABAergic mechanismBritish Journal of Pharmacology, 2006
- Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortexPain, 2004
- Evidence that central 5‐HT2A and 5‐HT2B/C receptors regulate 5‐HT cell firing in the dorsal raphe nucleus of the anaesthetised ratBritish Journal of Pharmacology, 2003
- Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8Life Sciences, 1996
- Paraesthesia of the infraorbital nerve following fracture of the zygomatic complexInternational Journal of Oral and Maxillofacial Surgery, 1987
- Anticonvulsant Drugs and Chronic PainClinical Neuropharmacology, 1984
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983